Iradimed (IRMD) Non Operating Investment Income (2014)

Iradimed (IRMD) posted quarterly Non Operating Investment Income of $2560.0 for Q4 2014, up 1869.23% on a QoQ basis from $130.0 in Q3 2014.

Iradimed (IRMD) Non Operating Investment Income (2014) Analysis & Trends

Iradimed has reported Non Operating Investment Income for 1 years, with the latest figure at $2560.0 in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Abbott Laboratories	199.63 Bn	194.02 Bn	7.27 Bn	-
2	Stryker	127.42 Bn	123.95 Bn	4.50 Bn	-
3	Medtronic	118.97 Bn	109.75 Bn	6.41 Bn	-
4	Boston Scientific	73.39 Bn	72.85 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.97 Bn	47.72 Bn	1.35 Bn	-
6	Dexcom	34.32 Bn	32.37 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn	-
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	-
9	Steris	23.04 Bn	22.56 Bn	684.20 Mn	-
10	Iradimed	1.11 Bn	1.05 Bn	15.16 Mn	-

Download Data